Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 73

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 73
---
 Extraordinary Shareholders’ Meeting of NLS” for more information on attending the NLS Meeting. If, on the record date, your ordinary shares are held in a brokerage account or by another nominee, you are considered the beneficial owner of ordinary shares held in “street name,” and the proxy materials are being forwarded to you by your broker or other nominee together with a voting instruction card. As the beneficial owner, you are also invited to attend the NLS Meeting. Because a beneficial owner is not the shareholder of record, you may not vote these shares in person at the NLS Meeting unless you obtain a proxy from the broker, trustee or nominee that holds your shares, giving you the right to vote the shares at the NLS Meeting. xiii Q.Who is entitled to vote at the NLS Meeting? Shareholders who are entered in the shareholder register maintained by our transfer agent, VStock Transfer, LLC as of September5, 2025, 11:59 pm CET (record date), are entitled to participate personally or be represented as provided for herein in order to exercise their shareholder rights with respect to the NLS meeting. Q.What constitutes a quorum at the NLS Meeting? Neither Swiss law nor the Articles provide any quorum requirements applicable to the NLS Meeting. Q.What are the Shareholder Support Agreements? Concurrently with the execution of the Merger Agreement, NLS entered into support agreements, each, a Support Agreement, with certain shareholders of NLS, or the Supporting Persons, covering approximately 35% of the outstanding NLS Common Shares. Pursuant to the Support Agreements, each Supporting Person has agreed, among other things, to vote its NLS Common Shares, and any other voting securities such Supporting Person might hold, in favor of the approval of (i) the issuance of NLS Common Shares equal to the required number of NLS Common Shares to serve as the Merger Consideration, and (ii) an ordinary capital increase under Swiss law, excluding the subscription rights of the existing holders of NLS Common Shares, for the purpose of making available the required number of NLS Common Shares to serve as the Merger Consideration. Similarly, Kadimastem and certain shareholders of Kadimastem entered into voting and support agreements. The Merger has been approved by the shareholders of Kadimastem. For a more complete description of the Support Agreements, please see the section entitled “ Certain Related Agreements — Support Agreements” in this proxy statement/prospectus. Q.How